Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
    • Education
  • Online Sections
    • Neurology Video Journal Club
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Null Hypothesis
    • Patient Pages
    • Translations
    • Topics A-Z
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
    • Education
  • Online Sections
    • Neurology Video Journal Club
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Null Hypothesis
    • Patient Pages
    • Translations
    • Topics A-Z
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Practice Current
  • Practice Buzz

User menu

  • Subscribe
  • My Alerts
  • Log in

Search

  • Advanced search
Neurology Clinical Practice
Home
A peer-reviewed clinical neurology journal for the practicing neurologist
  • Subscribe
  • My Alerts
  • Log in
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Practice Current
  • Practice Buzz

Share

December 2021; 11 (6) ResearchOpen Access

Improved Cognitive Function in the Tromsø Study in Norway From 2001 to 2016

Bente Johnsen, Bjørn Heine Strand, Ieva Martinaityte, Ellisiv B. Mathiesen, Henrik Schirmer
First published July 1, 2021, DOI: https://doi.org/10.1212/CPJ.0000000000001115
Bente Johnsen
Department of Clinical Medicine (BJ, IM, EBM, HS), UiT The Arctic University of Norway; Department of Medicine (BJ, IM), University Hospital of North Norway, Tromsø; Norwegian Institute of Public Health (BHS), Oslo; Department of Neurology (EBM), University Hospital of North Norway, Tromsø; Department of Cardiology (HS), Akershus University Hospital, Lørenskog; and Institute of Clinical Medicine (HS), University of Oslo, Norway.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bjørn Heine Strand
Department of Clinical Medicine (BJ, IM, EBM, HS), UiT The Arctic University of Norway; Department of Medicine (BJ, IM), University Hospital of North Norway, Tromsø; Norwegian Institute of Public Health (BHS), Oslo; Department of Neurology (EBM), University Hospital of North Norway, Tromsø; Department of Cardiology (HS), Akershus University Hospital, Lørenskog; and Institute of Clinical Medicine (HS), University of Oslo, Norway.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ieva Martinaityte
Department of Clinical Medicine (BJ, IM, EBM, HS), UiT The Arctic University of Norway; Department of Medicine (BJ, IM), University Hospital of North Norway, Tromsø; Norwegian Institute of Public Health (BHS), Oslo; Department of Neurology (EBM), University Hospital of North Norway, Tromsø; Department of Cardiology (HS), Akershus University Hospital, Lørenskog; and Institute of Clinical Medicine (HS), University of Oslo, Norway.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ellisiv B. Mathiesen
Department of Clinical Medicine (BJ, IM, EBM, HS), UiT The Arctic University of Norway; Department of Medicine (BJ, IM), University Hospital of North Norway, Tromsø; Norwegian Institute of Public Health (BHS), Oslo; Department of Neurology (EBM), University Hospital of North Norway, Tromsø; Department of Cardiology (HS), Akershus University Hospital, Lørenskog; and Institute of Clinical Medicine (HS), University of Oslo, Norway.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Henrik Schirmer
Department of Clinical Medicine (BJ, IM, EBM, HS), UiT The Arctic University of Norway; Department of Medicine (BJ, IM), University Hospital of North Norway, Tromsø; Norwegian Institute of Public Health (BHS), Oslo; Department of Neurology (EBM), University Hospital of North Norway, Tromsø; Department of Cardiology (HS), Akershus University Hospital, Lørenskog; and Institute of Clinical Medicine (HS), University of Oslo, Norway.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Full PDF
Citation
Improved Cognitive Function in the Tromsø Study in Norway From 2001 to 2016
Bente Johnsen, Bjørn Heine Strand, Ieva Martinaityte, Ellisiv B. Mathiesen, Henrik Schirmer
Neurol Clin Pract Dec 2021, 11 (6) e856-e866; DOI: 10.1212/CPJ.0000000000001115

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
70

Share

  • Article
  • Figures & Data
  • Info & Disclosures
Loading

Abstract

Background and Objectives Physical capacity and cardiovascular risk profiles seem to be improving in the population. Cognition has been improving due to a birth cohort effect, but evidence is conflicting on whether this improvement remains in the latest decades and what is causing the changes in our population older than 60 years. We aimed to investigate birth cohort differences in cognition.

Methods The study comprised 9,514 participants from the Tromsø Study, an ongoing longitudinal cohort study. Participants were aged 60–87 years, born between 1914 and 1956. They did 4 cognitive tests in 3 waves during 2001–2016. Linear regression was applied and adjusted for age, education, blood pressure, smoking, hypercholesterolemia, stroke, heart attack, depression, diabetes, physical activity, alcohol use, BMI, and height.

Results Cognitive test scores were better in later-born birth cohorts for all age groups, and in both sexes, compared with earlier-born cohorts. Increased education, physical activity, alcohol intake, decreasing smoking prevalence, and increasing height were associated with one-third of this improvement across birth cohorts in women and one-half of the improvement in men.

Discussion Cognitive results were better in more recent-born birth cohorts compared with earlier born, assessed at the same age. The improvement was present in all cognitive domains, suggesting an overall improvement in cognitive performance. The 80-year-olds assessed in 2015–2016 performed like 60-year-olds assessed in 2001. The improved scores were associated with increased education level, increase in modest drinking frequency, increased physical activity, and, for men, smoking cessation and increased height.

Embedded Image

The Western population is getting older, and in Norway, the population older than 70 years is estimated to increase from 12% today to 21% in 2060.1 It is well documented that aging is the largest risk factor for cognitive decline. Cognitive function has improved over the last century in the general adult population, a trend known as the Flynn effect.2 However, a negative Flynn effect has been reported in the latest decades of the twentieth century,3 suggesting that a plateau for the improvement has been reached. The improvement in cognition is probably a cohort effect, commenced by multifactorial change in the population on factors influencing the brain and its function.4

Modifiable risk factors for cognitive decline have been identified.5,-,9 Among these factors, education seems to be the most promising protecting factor for cognitive decline.4,5 The population-based Tromsø Study in Norway has gathered a broad range of multidisciplinary health information from the adult population of Tromsø for five decades. The study has found improvement in cardiovascular risk factor profiles10,11 and biomarkers of aging such as physical capasity measured by grip strength.12 Therefore, we aimed to determine whether cognition has improved in later-born cohorts of older adults assessed 15 years apart. If so, which factors have contributed the most to this improvement?

Methods

The Tromsø Study is the longest-running Norwegian ongoing population-based longitudinal cohort study, with repeated screening of inhabitants in the municipality Tromsø, Norway.13 Seven surveys (Tromsø 1–7) have been conducted since 1974. Participants were recruited based on the national registry data of adult inhabitants. Each survey included both new individuals and individuals who had participated before, based on a complex sampling design described elsewhere.13,14 Cognitive testing was introduced in Tromsø 5 and repeated in Tromsø 6 and Tromsø 7.13,-,15 The present study includes Tromsø 5–7 (Table 1 and Figure 1). Participants who had taken part in the second part of Tromsø 4 in 1994/95 and a random sample of participants attending for the first time14 were eligible for invitations to the second visit in Tromsø 5–7. For the second visit in Tromsø 5, 85% of those eligible attended (n = 5,939), in Tromsø 6, 64% (n = 7,350), and in Tromsø 7, 60% (n = 7,804).16 Participants aged 60–88 years who had completed at least 1 cognitive test (n = 9,514, 54.4% women) in Tromsø 5–7 were eligible for the present study. Of these, 6,034 had participated once, 2,708 twice, and 782 in all 3 surveys with 7 or 14–15 years apart. Those attending only Tromsø 5 had a higher mean age (Tromsø 5: 71.8 years; Tromsø 6: 65.9 years; and Tromsø 7: 65.2 years) and a higher percentage of participants with only primary education (85.7%) compared with those who participated only in Tromsø 7 (30.1%) and those participating in all 3 surveys (66%). Those only attending Tromsø 5 also reported less physical activity. They had a higher frequency of smokers, people with high blood pressure and hypercholesterolemia, but not more depression. (Table 2 and eTable 1, links.lww.com/CPJ/A301).

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table 1

Birth Cohorts and Age Bands by Tromsø Study Wave

Figure 1
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1 Selection of Participants From the Tromsø Study
View this table:
  • View inline
  • View popup
  • Download powerpoint
Table 2

Description of the Participants by Sex, Age, Survey, and Birth Cohort

Participants were stratified in 7-year birth cohorts and 7-year age bands to prevent overlapping birth cohorts, as Tromsø 5–7 were performed 7 years apart. The age-specific analyses were performed in 4 age bands: 60–66, 67–73, 74–80, and 80–87 years.

The Mini-Mental State Examination (MMSE) was excluded from the analyses as it was first introduced in 2008, and we aimed to explore trends since 2001. We, however, did 2 MMSE sensitivity tests: first excluding participants with MMSE scores of 19 or lower (n = 10 in Tromsø 6 and n = 34 in Tromsø 7) and second excluding participants with MMSE 20–24 (n = 141 in Tromsø 6, n = 397 in Tromsø 7), to check for impact of participants with probable neurodegenerative disease.

Measurements of Cognitive Function

Word test 1 (WT1) is a 12-word memory test of short-term verbal memory.6 The participants were given 2 minutes to complete a free immediate recall of 12 nouns that were shown written on a board and read aloud at 5-second intervals. One point was given for correct recall of each word. Scores ranged from 0 to 12.17,18 Word test 2 (WT2) is a test of long-term verbal memory, episodic memory, and the ability to use learning strategies.6 The 12 words from WT1 were shown and read aloud again mixed with 12 new nouns. The participants were asked to identify each word as new or known. One point was given for each correctly identified word. Points ranged from 0 to 24.17,18 The digit symbol coding test (DSCT) is part of the Wechsler Adult Intelligence Scale.19 It is used to examine perceptual processing, perceptual motor speed, and memory20 and is sensitive enough to reveal small changes in cognition, as it is influenced by psychomotor ability, sustained attention, processing speed, episodic memory, and executive function.9 This test pairs 9 numbers with 9 symbols. Participants were asked to fill in as many correct symbols in numbered blank squares as they could in 90 seconds without skipping a square. The number of correct symbols was the score of the test.6,21 In the finger-tapping test (FTT), a test measuring psychomotor speed,22 the participants tapped their nondominant index finger on a button for four 10-second rounds. The result was the mean tapping count of the last 3 rounds.

Risk Factors for Cognitive Decline, Possibly Affecting Cohort Differences

We chose factors that are proposed as detrimental or beneficial for cognitive function: education, high blood pressure, smoking hypercholesterolemia, stroke, alcohol consumption, diabetes, depression, heart attack, physical activity, height, and body mass index (BMI).5,6,23,-,25 Height is an indicator of nutrition early in life and health care.26 Participants filled out questionnaires on life style. For details, see eAppendix 1 (links.lww.com/CPJ/A301).

Statistical Analyses

Data from all study waves were pooled and analyzed as 1 set. First, to investigate whether cognitive test scores improved in later-birth cohorts, we performed a multiple linear regression analysis in each of the age bands, with the respective cognitive tests as the dependent variable and study wave as the independent covariate. All models were adjusted by age and sex. Second, to investigate how much other covariates mediated the changes in test scores between study waves, covariates were added one by one in the whole age span (in the following order: age, education, blood pressure, hypercholesterolemia, smoking, stroke, previous heart attack, depression, diabetes, physical activity, alcohol units, alcohol frequency, height, and BMI), and we investigated the change in percent in the coefficient for the study wave. The interaction terms age × study waves and study wave × sex and sex × age and sex × age × study wave were included to allow for different changes over time by sex and age. We used Stata 14.2. There were 2,852 missing values in one or more of the covariates, which were adjusted with multiple imputation by chained equation. The imputation was based on the variables age, sex, and study wave and the respective cognitive variable. The cognitive test scores were not imputed. All missing values of the mediators were below 3.5%, except for alcohol consumption (n = 2,707), depression (n = 1,099), and physical activity. Physical activity in Tromsø 5 had a high missing rate (n = 2,852), as the participants older than 70 years (n = 1,615) were asked a different question.

Standard Protocol Approvals, Registrations, and Patient Consents

The study was funded by Northern Norway Regional Health Authority (Helse Nord RHF). The Regional Committee for Medical and Health Research Ethics approved the study (REK Nord, reference 2016/389). Written informed consent was given by all participants.

Data Availability

Data cannot be made public as legal restrictions are set by the Tromsø Study Data and Publication Committee. Researchers can apply for data access at uit.no/research/tromsostudy/project?pid=709148.

Results

The mean age of the participants was 68.8 years, with the range 60–87 years and interquartile range 63–73. Description of participants can be found in Table 2. Education levels in the Tromsø municipality have increased markedly over the last century (eFigure 1, links.lww.com/CPJ/A301). We found an increase over time in people drinking alcohol 2 or more times per week, but they did not increase the amount of alcohol per occasion. Later-born participants reported more leisure exercise and smoking prevalence declined over time, especially in men. Rates of hypercholesterolemia decreased, and participants had better controlled blood pressure. There was a minor increase in BMI and diabetes, but little change in number of other comorbid conditions.

Scores in all 4 cognitive tests improved in later-born birth cohorts for all age bands, in both sexes by 5%–51% compared with earlier born tested at the same age (Table 3). The greatest improvement was seen in DSCT and the least in WT2.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table 3

Cognitive Crude Mean Scores at Tromsø 5 and Tromsø 7 and Difference in Regression Coefficient in Adjusted Models

Women scored better on short-term memory, long-term verbal and episodic memory, visuospatial function, perceptual motor speed, and sustained attention (WT1, WT2, and DSCT) compared with men (Table 3 and Figure 2). They also had higher age-specific improvement than men did over time (interaction for sex by study wave: p < 0.05 for all 3 cognitive tests). For psychomotor speed (FTT), however, the sex difference was reversed, with higher scores and larger improvement over time for men than for women. In DSCT, men improved more than women at older age (∆β = 0.1), and the opposite for the FTT, on which women improved more at older age (∆β = 0.02). On the FTT, older women had larger improvement over time in cognitive test scores than the younger women (p = 0.008), whereas for DSCT, younger women improved the most.

Figure 2
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2 Differences of Cognitive Scores With 14/15 Years Apart

Estimation is done with linear regression with 95% confidence interval (CI). The y-axis has scale brake for WT1, WT2 and FTT to better illustrate the age-specific improvement over time.

When adjusted for all included mediators, the cognitive test score improvements in later-born were still statistically significant, except in the oldest men (Table 3), indicating other factors mediating the improvement in the younger age bands. The most prominent mediator for improved cognitive scores in later-born birth cohorts was education. When the early-born and most recent born birth cohorts were compared, education mediated 40.6% of the improvement in female WT1 scores and 52.9% in male scores. It was less, but still a substantial mediator for the improvement on WT2, mediating more than 20% for both sexes. Education was mediating 19.9% in women and 31.3% in men, of the improvement on the DSCT results, whereas the results of FTT scores improved by 29.4% and 35.3% in women and men, respectively.

Increase in alcohol drinking frequency mediated 24.9% of the improvement in FTT score in women and 17.6% in men. For WT1, it mediated 23% of the improvement in women and 19.5% in men. Within each occasion, the effect of increasing consumption had a weak (0.6% or less) negative trend on all cognitive tests, equal for both sexes. Reporting more than 5 units of alcohol per occasion, was for men associated with decreasing test performance on DSCT and FTT. (men p < 0.01, women p > 0.05).

Increased physical activity was associated with improved test scores, especially in short-term memory and psychomotor speed, with a mediating effect of 4.2%–6.8% on cognitive outcomes.

Among men, less smoking in later-born birth cohorts mediated 12.2% of the improvement in the FTT and 9.3% of improvement in WT1, whereas in women, smoking was not a mediator. Increased height in later-born cohorts was associated with 21.3% of the improvement in WT1 in men and 7.6% in women. Conjointly, increased education, physical activity, alcohol intake, height and decreased smoking prevalence in later-born birth cohorts, mediated on average 34.4% (range 24.5%–47.7%) of the improvement in women's results on the 4 cognitive tests. Men's average improvement in the 4 cognitive tests on the same conjoined factors was 51.6% (range 35.8–73.4%).

We performed sensitivity tests excluding those having had a stroke, with no substantial difference in the results. We also excluded participants with Parkinson disease and all those with MMSE scores of 19 or below with no substantial difference in results. Excluding those with MMSE <25 from Tromsø 6 and Tromsø 7, enlarged improvement in cognitive scores as MMSE was not performed in Tromsø 5 (n = 581), the reference group. However, after removing those testing in the lower areas on MMSE in T6 and T7, the covariates had less influence on the change, with largest effect on short time memory (eTables 2–4 links.lww.com/CPJ/A301).

Discussion

In this large population-based study, we found improvement in cognitive test scores in more recently born birth cohorts. The scale of these differences varied in the 4 cognitive tests, but on the DSCT, the improvement corresponded to 12 years for women and 10 years for men, meaning that 70- to 72-year-olds in 2015/16 performed as 60-year-olds did in 2001. For WT1, the improvement was 10 years for both sexes, and for WT2, the test score improvement in was corresponding 20 years for both sexes, meaning that for recognition, 80 is the new 60 (Figure 2).

These positive associations were evident in all age bands and in both sexes represented in all 4 cognitive tests, covering different areas of cognition. The strongest mediating factors associated with improved cognition in more recent born birth cohorts were higher education levels, increased height, and smoking cessation for men and increased physical activity for both sexes. Higher cognitive test scores in those reporting more frequent, but yet moderate alcohol consumption was also observed.

Education was the most prominent mediator in the short-term memory test (WT1), suggesting that education may benefit short-term memory. Our results confirm the findings of similar studies in other Western countries where educational levels have improved in the last century.27,-,31 Also in this study's population, education levels have changed immensely over the last century in both sexes (Table 2 and eFigure 1, links.lww.com/CPJ/A301). This indicates that education improves not only resilience to damage and cognitive reserve capacity but also cognition in those without manifest neurodegenerative disease.

Psychomotor speed also improved over birth cohorts. This supports the possible relationship between the improvement in cognition and the improved physical strength shown in earlier studies12 and the weak association between cardiovascular risk factors and cognition.27

In the Tromsø Study, alcohol units per occasion did not change much from 2001 to 2015, but the frequency of occasions consuming alcohol increased. Excessive alcohol use is a well-known risk factor for cognitive decline.32 Studies have shown a J-shaped association between cognitive capacity and alcohol, suggesting a protective effect of moderate consumption and damage to the brain with excessive use.23,32 A study from 2010 using data from the Tromsø Study suggested improved cognition with increasing wine intake within a moderate range. As alcohol consumption increases with income and educational level, the authors thought that their findings were due to residual confounding factors, despite adjustment for education.33 Another study confirmed the findings, but explained the improvement in cognitive performance to be related to sex differences, as women drank more wine and men drank more beer and liquor, and women outperformed men in cognitive tests.4 A cutoff at 21 >units per week has been suggested as a risk factor for dementia,5 and a large meta-analysis concluded that people older than 60 years increased their dementia risks with more than 2 times per week.34 The majority of the population in the Tromsø Study were at or below the advocated limit for harmful drinking5,34 (Table 2). The moderately increased frequency of alcohol consumption in this study, however, was still strongly associated with the improved score on cognitive tests for both sexes. Confounding of not measured factors could be a possible explanation for this contradictory epidemiologic effect. Moderate alcohol consumption is also associated with higher education.5,6 With increasing years of education, a higher cognitive capacity could make brains more resilient to the damaging effects of alcohol. Moderate alcohol consumption is also linked with being socially active,35 and frequency of consuming alcohol could be a confounder marking social interactions. Using abstainers as the reference group could introduce a selection bias, as abstainers in some studies have shown poorer health compared with moderate consumers.36

Our analysis showed that physical activity was positively associated with cognitive test scores over birth cohorts, with a larger effect in men. It is recommended for people to be physically active to reduce the risk of cognitive decline.37,38 Previous studies in the Tromsø Study, with 7 years between analyzed waves, have also found low physical activity to be associated with lower scores in cognitive testing, but only in women.6 The positive effect of exercise in men in our study could be due to longer time of 14/15 years between the survey waves and a higher mean age. Our findings also comply with the same study on smoking, which had an inverse association with cognition in both sexes, and improvement in other cardiovascular risk factors such as hypertension and hypercholesterolemia to be only weakly associated with cognitive test scores.

With a large population of almost 10,000 people evaluated with 4 different cognitive tests covering different areas of cognition, and showing the same trends, the results are robust. The high attendance rate of 65% or higher in all 3 surveys ensures generalizability.16

The study included few excessive alcohol users and few with extreme obesity. It was not possible to make a variable for unit alcohol per week. This would have made the alcohol findings more comparable to the international literature. Participants were not asked about financial income in all survey waves.

In repeated testing, there could be introduced a learning bias. Reports on the subject are dissimilar. Some report an improved IQ score by 5–6 points2; others report a learning bias with mean test-retest interval of 47 days.18 With longer test-retest intervals of mean 370 days, 1 study reports that reliability improved in a geriatric population.17 Accordingly, we assume that the learning bias in our study, for the 37% that were tested more than once, will be very small as there is 15 years between testing.

Cognitive test scores were improved in the more recent born birth cohorts in all ages and in both sexes. The scale of these differences varied, but for some cognitive areas, 80 is the new 60. The improvement is positively associated with increased education level, increase in drinking frequency, increased physical activity, and, for men, smoking cessation and increased height.

TAKE-HOME POINTS

  • → Later-born birth cohorts have better score on cognitive tests compared with earlier born in a population aged 60–87 years.

  • → In cognitive domains such as psychomotor ability, sustained attention, processing speed, episodic memory, and executive function, the improvement corresponded to 12 years for women and 10 years for men, indicating 70- to 72-year-olds in 2015/16 performed as 60-year-olds did in 2001.

  • → For short-term memory, the improvement was 10 years for both sexes. For long-term verbal memory, episodic memory, and the ability to use learning strategies, the test score improvement corresponded to 20 years for both sexes, indicating that for these domains, 80 is the new 60.

  • → The improvement was positively associated with increased education level, increased drinking frequency, increased physical activity, and, for men, smoking cessation and increased height.

Study Funding

Northern Norway Regional Health Authority (Helse Nord RHF) grant number: HNF1407-18.

Disclosure

The authors report no disclosures relevant to the manuscript. Full disclosure form information provided by the authors is available with the full text of this article at Neurology.org/cp.

Appendix Authors

Table

Footnotes

  • Funding information and disclosures are provided at the end of the article. Full disclosure form information provided by the authors is available with the full text of this article at Neurology.org/cp.

  • Received January 15, 2021.
  • Accepted May 21, 2021.
  • Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology.

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND), which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.

References

  1. 1.↵
    1. Sentralbyrå S
    . Lavere Befolkningsvekst Framover. 2018. Accessed April 23, 2020. ssb.no/befolkning/artikler-og-publikasjoner/lavere-befolkningsvekst-framover
  2. 2.↵
    1. Flynn JR
    . Massive IQ gains in 14 nations: what IQ tests really measure. Psychol Bull. 1987;101:171-191.
    OpenUrlCrossRef
  3. 3.↵
    1. Dutton E,
    2. van der Linden D,
    3. Lynn R
    . The negative Flynn effect: a systematic literature review. Intelligence. 2016;59:163-169.
    OpenUrl
  4. 4.↵
    1. Corley J,
    2. Cox SR,
    3. Deary IJ
    . Healthy cognitive ageing in the Lothian Birth Cohort studies: marginal gains not magic bullet. Psychol Med. 2018;48(2):187-207.
    OpenUrlCrossRef
  5. 5.↵
    1. Livingston G
    . Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet. 2020;396(10248):413-446.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Arntzen KA,
    2. Schirmer H,
    3. Wilsgaard T,
    4. Mathiesen EB
    . Impact of cardiovascular risk factors on cognitive function: the Tromso study. Eur J Neurol. 2011;18(5):737-743.
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. Mungas D,
    2. Gavett B,
    3. Fletcher E,
    4. Farias ST,
    5. DeCarli C,
    6. Reed B
    . Education amplifies brain atrophy effect on cognitive decline: implications for cognitive reserve. Neurobiol Aging. 2018;68:142-150.
    OpenUrl
  8. 8.↵
    1. Sattler C,
    2. Toro P,
    3. Schonknecht P,
    4. Schroder J
    . Cognitive activity, education and socioeconomic status as preventive factors for mild cognitive impairment and Alzheimer's disease. Psychiatry Res. 2012;196(1):90-95.
    OpenUrlCrossRefPubMed
  9. 9.↵
    1. Hestad K,
    2. Engedal K,
    3. Schirmer H,
    4. Strand BH
    . The effect of blood pressure on cognitive performance. An 8-year follow-up of the Tromso study, comprising people aged 45-74 years. Front Psychol. 2020;11:607.
    OpenUrl
  10. 10.↵
    1. Mannsverk J,
    2. Wilsgaard T,
    3. Mathiesen EB, et al
    . Trends in modifiable risk factors are associated with declining incidence of hospitalized and nonhospitalized acute coronary heart disease in a population. Circulation. 2016;133(1):74-81.
    OpenUrlAbstract/FREE Full Text
  11. 11.↵
    1. Hopstock LA,
    2. Bonaa KH,
    3. Eggen AE, et al
    . Longitudinal and secular trends in blood pressure among women and men in birth cohorts born between 1905 and 1977: the Tromso study 1979 to 2008. Hypertension. 2015;66(3):496-501.
    OpenUrlCrossRefPubMed
  12. 12.↵
    1. Strand BH,
    2. Bergland A,
    3. Jorgensen L,
    4. Schirmer H,
    5. Emaus N,
    6. Cooper R
    . Do more recent born generations of older adults have stronger grip? A comparison of three cohorts of 66- to 84-year-olds in the Tromso study. J Gerontol A Biol Sci Med Sci. 2019;74(4):528-533.
    OpenUrl
  13. 13.↵
    1. Jacobsen BK,
    2. Eggen AE,
    3. Mathiesen EB,
    4. Wilsgaard T,
    5. Njolstad I
    . Cohort profile: the Tromso study. Int J Epidemiol. 2012;41(4):961-967.
    OpenUrlCrossRefPubMed
  14. 14.↵
    1. Eggen AE,
    2. Mathiesen EB,
    3. Wilsgaard T,
    4. Jacobsen BK,
    5. Njolstad I
    . The sixth survey of the Tromso Study (Tromso 6) in 2007-08: collaborative research in the interface between clinical medicine and epidemiology: study objectives, design, data collection procedures, and attendance in a multipurpose population-based health survey. Scand J Public Health. 2013;41(1):65-80.
    OpenUrlCrossRefPubMed
  15. 15.↵
    1. Lu K,
    2. Nicholas JM,
    3. Collins JD, et al
    . Cognition at age 70: life course predictors and associations with brain pathologies. Neurology. 2019;93(23):e2144-e56.
    OpenUrlPubMed
  16. 16.↵
    1. Berrington de Gonzalez A,
    2. Hartge P,
    3. Cerhan JR, et al
    . Body-mass index and mortality among 1.46 million white adults. New Engl J Med. 2010;363(23):2211-2219.
    OpenUrlCrossRefPubMed
  17. 17.↵
    1. Woods SP,
    2. Scott JC,
    3. Conover E, et al
    . Test-retest reliability of component process variables within the Hopkins Verbal Learning Test-Revised. Assessment. 2005;12(1):96-100.
    OpenUrlCrossRefPubMed
  18. 18.↵
    1. Benedict RHB,
    2. Schretlen D,
    3. Groninger L,
    4. Brandt J
    . Hopkins Verbal Learning Test—Revised: normative data and analysis of inter-form and test-retest reliability. Clin Neuropsychol. 2010;12(1):43-55.
    OpenUrl
  19. 19.↵
    1. Wechsler D
    . WAIS-IV: Wechsler Adult Intelligence Scale. Psychological Corp.; 2008.
  20. 20.↵
    1. Joy S,
    2. Kaplan E,
    3. Fein D
    . Speed and memory in the WAIS-III Digit Symbol—Coding subtest across the adult lifespan. Arch Clin Neuropsychol. 2004;19(6):759-767.
    OpenUrlCrossRefPubMed
  21. 21.↵
    1. Jaeger J
    . Digit symbol substitution test: the case for sensitivity over specificity in neuropsychological testing. J Clin Psychopharmacol. 2018;38(5):513-519.
    OpenUrlCrossRefPubMed
  22. 22.↵
    1. Roalf DR,
    2. Rupert P,
    3. Mechanic-Hamilton D, et al
    . Quantitative assessment of finger tapping characteristics in mild cognitive impairment, Alzheimer's disease, and Parkinson's disease. J Neurol. 2018;265(6):1365-1375.
    OpenUrl
  23. 23.↵
    1. Organization WH
    . Risk Reduction of Cognitive Decline and Dementia: WHO Guidelines. WHO; 2019.
  24. 24.↵
    1. Baumgart M,
    2. Snyder HM,
    3. Carrillo MC,
    4. Fazio S,
    5. Kim H,
    6. Johns H
    . Summary of the evidence on modifiable risk factors for cognitive decline and dementia: a population-based perspective. Alzheimers Dement. 2015;11(6):718-726.
    OpenUrlCrossRefPubMed
  25. 25.↵
    1. Fischer CE,
    2. Kortebi I,
    3. Karameh WK, et al
    . Examining the link between cardiovascular risk factors and neuropsychiatric symptoms in mild cognitive impairment and major depressive disorder in remission. J Alzheimers Dis. 2019;67(4):1305-1311.
    OpenUrl
  26. 26.↵
    1. Sundet J,
    2. Barlaug D,
    3. Torjussen T
    . The end of the Flynn effect? A study of secular trends in mean intelligence test scores of Norwegian conscripts during half a century. Intelligence. 2004;32(4):349-362.
    OpenUrl
  27. 27.↵
    1. Thorvaldsson V,
    2. Karlsson P,
    3. Skoog J,
    4. Skoog I,
    5. Johansson B
    . Better cognition in new birth cohorts of 70 year olds, but greater decline thereafter. J Gerontol B Psychol Sci Soc Sci. 2017;72(1):16-24.
    OpenUrlCrossRefPubMed
  28. 28.↵
    1. Rönnlund M,
    2. Nilsson LG
    . The magnitude, generality, and determinants of Flynn effects on forms of declarative memory and visuospatial ability: time-sequential analyses of data from a Swedish cohort study. Intelligence. 2008;36(3):192-209.
    OpenUrlCrossRef
  29. 29.↵
    1. Christensen K,
    2. Thinggaard M,
    3. Oksuzyan A, et al
    . Physical and cognitive functioning of people older than 90 years: a comparison of two Danish cohorts born 10 years apart. Lancet. 2013;382(9903):1507-1513.
    OpenUrlCrossRefPubMed
  30. 30.↵
    1. Bancks M,
    2. Alonso A,
    3. Allen N,
    4. Yaffe K,
    5. Carnethon M
    . Temporal trends in cognitive function of older US adults associated with population changes in demographic and cardiovascular profiles. J Epidemiol Community Health. 2019;73(7):612-618.
    OpenUrlAbstract/FREE Full Text
  31. 31.↵
    1. Munukka M,
    2. Koivunen K,
    3. von Bonsdorff M, et al
    . Birth cohort differences in cognitive performance in 75- and 80-year-olds: a comparison of two cohorts over 28 years. Aging Clin Exp Res. 2021;33(1):57-65.
    OpenUrl
  32. 32.↵
    1. Sachdeva A,
    2. Chandra M,
    3. Choudhary M,
    4. Dayal P,
    5. Anand KS
    . Alcohol-related dementia and neurocognitive impairment: a review study. Int J High Risk Behav Addict. 2016;5(3):e27976.
    OpenUrl
  33. 33.↵
    1. Arntzen KA,
    2. Schirmer H,
    3. Wilsgaard T,
    4. Mathiesen EB
    . Moderate wine consumption is associated with better cognitive test results: a 7 year follow up of 5033 subjects in the Tromso Study. Acta Neurol Scand Suppl. 2010(190):23-29.
  34. 34.↵
    1. Xu W,
    2. Wang H,
    3. Wan Y, et al
    . Alcohol consumption and dementia risk: a dose-response meta-analysis of prospective studies. Eur J Epidemiol. 2017;32(1):31-42.
    OpenUrlCrossRefPubMed
  35. 35.↵
    1. Kelly S,
    2. Olanrewaju O,
    3. Cowan A,
    4. Brayne C,
    5. Lafortune L
    . Alcohol and older people: a systematic review of barriers, facilitators and context of drinking in older people and implications for intervention design. PLoS One. 2018;13(1):e0191189.
    OpenUrl
  36. 36.↵
    1. Ormstad H,
    2. Rosness TA,
    3. Bergem AL,
    4. Bjertness E,
    5. Strand BH,
    6. Group G
    . Alcohol consumption in the elderly and risk of dementia related death—a Norwegian prospective study with a 17-year follow-up. Int J Neurosci. 2016;126(2):135-144.
    OpenUrl
  37. 37.↵
    1. Mandolesi L,
    2. Polverino A,
    3. Montuori S, et al
    . Effects of physical exercise on cognitive functioning and wellbeing: biological and psychological benefits. Front Psychol. 2018;9:509.
    OpenUrl
  38. 38.↵
    1. Morland C,
    2. Andersson KA,
    3. Haugen OP, et al
    . Exercise induces cerebral VEGF and angiogenesis via the lactate receptor HCAR1. Nat Commun. 2017;8:15557.
    OpenUrlCrossRefPubMed

The Nerve!: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • Abstract
    • Methods
    • Results
    • Discussion
    • Study Funding
    • Disclosure
    • Appendix Authors
    • Footnotes
    • References
  • Figures & Data
  • Info & Disclosures
Advertisement

Related Articles

  • No related articles found.

Topics Discussed

  • Cohort studies
  • Intelligence
  • Risk factors in epidemiology
  • Cognitive aging
  • Cognitive neuropsychology in dementia

Alert Me

  • Alert me when eletters are published
Neurology: Clinical Practice: 12 (3)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • Neurology: Education
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology: Clinical Practice |  Print ISSN: 2163-0402
Online ISSN: 2163-0933

© 2022 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise